G-100(Magenta Therapeutics)

N/A

Report date: 2023/05/08 13:45:20

Base Information

Drug NameG-100(Magenta Therapeutics)
Drug Alias NameG-100
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionImmunosuppressants
TargetsNot applicable
Therapy Area/IndicationsGraft vs Host DiseaseHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMagenta Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMagenta Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGraft vs Host DiseaseHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A